Provided by Tiger Trade Technology Pte. Ltd.

60 degrees pharmaceuticals, Inc.

1.10
-0.0100-0.90%
Post-market: 1.04-0.0597-5.43%19:36 EDT
Volume:154.30K
Turnover:166.10K
Market Cap:3.87M
PE:-0.17
High:1.16
Open:1.06
Low:1.01
Close:1.11
52wk High:8.62
52wk Low:0.8400
Shares:3.52M
Float Shares:1.77M
Volume Ratio:0.22
T/O Rate:8.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.3166
EPS(LYR):-11.7369
ROE:-332.85%
ROA:-127.11%
PB:-0.56
PE(LYR):-0.09

Loading ...

60 Degrees highlights interim tafenoquine data, caps enrollment

TIPRANKS
·
Oct 06

60 Degrees Pharmaceuticals - to Unblind Severe Babesiosis Study; Results Expected January 2027

THOMSON REUTERS
·
Oct 06

60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-Snda Meeting with FDA

THOMSON REUTERS
·
Oct 06

60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA

GlobeNewswire
·
Oct 06

60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar

GlobeNewswire
·
Oct 01

60 Degrees Advances Babesiosis Treatment With FDA Submission

TIPRANKS
·
Sep 15

60 Degrees Pharmaceuticals - Target Supplemental Nda Submission March-April 2027 - SEC Filing

THOMSON REUTERS
·
Sep 15

60 Degrees Pharmaceuticals - Submits Statement of Interest to FDA Requesting Commissioner's National Priority Voucher for Arakoda - SEC Filing

THOMSON REUTERS
·
Sep 15

60 Degrees Pharmaceuticals Updates Strategy for Tick-Borne Diseases

TIPRANKS
·
Sep 09

60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 03

Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)

TIPRANKS
·
Aug 17

60 Degrees Pharmaceuticals Q2 EPS USD -0.9

THOMSON REUTERS
·
Aug 15

60 Degrees Pharmaceuticals Q2 Operating Expenses USD 2.33 Million

THOMSON REUTERS
·
Aug 15

Press Release: 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results

Dow Jones
·
Aug 15

60 Degrees Pharma Q2 FY26 Net Loss Widens 30.6% to $2.26 Million; Revenue More than Doubles to $207,898

Reuters
·
Aug 15

60 Degrees Pharmaceuticals Holds Annual Shareholder Meeting

Reuters
·
Aug 07

60 Degrees Pharmaceuticals Issues Series A, Series B Warrants Exercisable at $1.49 in $1 Million Private Placement

Reuters
·
Aug 05

60 Degrees Pharmaceuticals Completes Private Placement to Raise Capital

TIPRANKS
·
Aug 05

60 Degrees Pharmaceuticals to sell shares and warrants in private placement

TIPRANKS
·
Jul 31

60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced at-the-Market Under NASDAQ Rules

THOMSON REUTERS
·
Jul 31